Nanotechnology in the treatment of infectious diseases

Adam Friedman, Karin Blecher Paz

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Nosocomial and community-acquired infections caused by multidrug-resistant (MDR) pathogens is rising at an alarming rate [1, 2]. Microbial resistance has developed as a result of the ease with which microorganisms can acquire and transfer antibiotic-resistant determinants as well as the inherent resistance in some species. In addition, the abuse of broad spectrum antibiotics has further influenced the development of antibiotic-resistant strains [3-6]. As a result, resistance to antibiotics and conventional therapies has become a public health threat resulting in increased patient morbidity and mortality, highlighting the need for novel approaches in the development of antimicrobial agents [7-9].

Original languageEnglish (US)
Title of host publicationNanotechnology in Dermatology
PublisherSpringer New York
Pages187-200
Number of pages14
Volume9781461450344
ISBN (Electronic)9781461450344
ISBN (Print)1461450330, 9781461450337
DOIs
StatePublished - Jul 1 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Nanotechnology in the treatment of infectious diseases'. Together they form a unique fingerprint.

  • Cite this

    Friedman, A., & Blecher Paz, K. (2013). Nanotechnology in the treatment of infectious diseases. In Nanotechnology in Dermatology (Vol. 9781461450344, pp. 187-200). Springer New York. https://doi.org/10.1007/978-1-4614-5034-4_18